Chinese biotech 3SBIO launches up to $712 million HK IPO: term sheet

May 26 2015 11:43PM EST | Source: REUTERS Technology

(Reuters) - Biotech company 3SBIO, which delisted from the Nasdaq two years ago, on Wednesday launched an up to $712 million IPO in Hong Kong to fund acquisitions and recruit staff to help it grab a bigger piece of the booming Chinese drug market.